Suicidal behavior in the older patient with schizophrenia

scientific article

Suicidal behavior in the older patient with schizophrenia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2217/AHE.11.23
P932PMC publication ID3198783
P698PubMed publication ID22028735
P5875ResearchGate publication ID51746659

P2093author name stringJohn Kasckow
Sidney Zisook
Lauren Fox
Lori Montross
Laurie Prunty
P2860cites workInterventions for depressed elderly primary care patientsQ58391664
Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivityQ59668672
Suicide behaviour over 18 months in recent onset schizophrenic patients: The effects of CBTQ59784180
The Iowa 500: suicide in mania , depression, and schizophreniaQ66921036
Risk factors for suicide among patients with schizophreniaQ68527816
Patterns of self-destructive behaviour in schizophreniaQ69534526
Mortality in schizophrenia. A ten-year follow-up based on the Stockholm County inpatient registerQ69538086
Suicide in Chronic SchizophreniaQ72534176
Suicidality and substance misuse in first-admitted subjects with psychotic disorderQ73187020
Suicide Risk in Placebo vs Active Treatment in Placebo-Controlled Trials for SchizophreniaQ73270020
The relationship of akathisia with suicidality and depersonalization among patients with schizophreniaQ74404689
Treatment of schizophrenia 1999. The expert consensus guideline seriesQ77918229
Relapse prevention and recovery in the treatment of schizophreniaQ79842985
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic studyQ82593050
[Influence of positive and negative symptoms on suicidal behaviour in schizophrenia. Review of current literature]Q82764297
The Lifetime Risk of Suicide in SchizophreniaQ22253035
Suicide as an outcome for mental disorders. A meta-analysisQ28244203
Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndromeQ28268543
Suicide among patients with schizophrenia: a consideration of risk and protective factorsQ28293391
Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideationQ28307938
Schizophrenia--a high-risk factor for suicide: clues to risk reductionQ30312094
Schizophrenics kill themselves too: a review of risk factors for suicideQ30451676
Suicide and schizophrenia: data from a prospective community treatment studyQ30583560
Do antipsychotic medications decrease the risk of suicide in patients with schizophrenia?Q33540378
Remission in depressed geriatric primary care patients: a report from the PROSPECT studyQ33579484
Substance use disorders in schizophrenia: review, integration, and a proposed modelQ33865680
Suicide attempts and associated factors in older adults with schizophreniaQ33893234
Psychotherapy and recovery from schizophrenia: A review of potential applications and need for future studyQ33893244
Practice guideline for the treatment of patients with schizophrenia, second edition.Q33976372
Where schizophrenic patients commit suicide: a review of suicide among inpatients and former inpatientsQ33990881
The management of suicidality: assessment and interventionQ34064574
Mortality in schizophrenia: a measurable clinical endpointQ34183484
Suicide and schizophreniaQ34305454
Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled studyQ34571739
Elderly patients with schizophrenia and depression: diagnosis and treatmentQ34707472
Treatment of Subsyndromal Depressive Symptoms in Middle-Age and Older Patients With Schizophrenia: Effect of Age on ResponseQ34819160
Co-occurring depressive symptoms in the older patient with schizophreniaQ35008098
Suicidality in middle aged and older patients with schizophrenia and depressive symptoms: relationship to functioning and Quality of LifeQ35055345
The interpersonal theory of suicideQ35088289
Maximizing the synergy between pharmacotherapy and psychosocial therapies for schizophreniaQ35102485
Suicide and schizophrenia: a review of literature for the decade (1990-1999) and implications for mental health nursingQ35122924
Case-control study of the relationship of depressive symptoms to suicide in a community-based sample of individuals with schizophrenia in ChinaQ35150505
Clinical and health services relationships between major depression, depressive symptoms, and general medical illnessQ35189628
Depression and cardiovascular disease: mechanisms of interactionQ35189643
Integrated treatment of schizophreniaQ35576671
Antisuicide properties of psychotropic drugs: a critical reviewQ35668658
Suicide risk in schizophrenia: learning from the past to change the futureQ35738863
Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine.Q36091773
Schizophrenia and suicide: systematic review of risk factorsQ36182528
Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinationsQ36183115
Developing psychological perspectives of suicidal behaviour and risk in people with a diagnosis of schizophrenia: we know they kill themselves but do we understand why?Q36710460
Managing suicidality in schizophreniaQ36933486
Suicide risk in schizophrenia: explanatory models and clinical implications, The Schematic Appraisal Model of Suicide (SAMS).Q36962311
Cognitive-behavioral interventions to reduce suicide behavior: a systematic review and meta-analysisQ37039395
Prevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groups.Q37061576
Vascular factors and depressionQ37152050
Suicide within 12 months of contact with mental health services: national clinical surveyQ37449041
Diagnosis of secondary depression in schizophrenia: implications for DSM-IV.Q37755444
Depression, attempted suicide, and suicide in patients with chronic schizophreniaQ38161346
Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trialQ38383845
'Akinetic Depression' in SchizophreniaQ39206918
Conditions predisposing to suicide: a reviewQ39619249
Suicide among schizophrenics: a reviewQ39813674
Command hallucinations in outpatients with schizophreniaQ40413899
Cognitive approach to depression and suicidal thinking in psychosis. 2. Testing the validity of a social ranking modelQ40736157
Explaining the gender difference in depressive symptomsQ41704213
Suicidality before and in the early phases of first episode psychosisQ43095829
Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trialQ43111012
San Diego Suicide Study. III. Relationships between diagnoses and stressorsQ43647590
Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration databaseQ43726217
A study of suicide in schizophrenic in-patientsQ43965320
Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia.Q44029969
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).Q44268852
San Diego Suicide Study. II. Substance abuse in young casesQ44303203
Suicidal ideation in patients with schizophreniaQ44588355
International Multisite Double-Blind Trial of the Atypical Antipsychotics Risperidone and Olanzapine in 175 Elderly Patients With Chronic SchizophreniaQ44650318
Reducing the risk for suicide in schizophrenia and affective disordersQ44662799
Observations on suicide in chronic schizophrenicsQ44696663
Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trialQ44783938
Suicidal ideation and suicide attempts among middle-aged and older patients with schizophrenia spectrum disorders and concurrent subsyndromal depressionQ46086521
Risk factors for completed suicide in schizophrenia.Q46487086
Risk factors of suicide among schizophrenics.Q47344164
OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial.Q47345355
Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessmentQ47351642
Depression, hopelessness and suicide in chronic schizophreniaQ47356589
Discovering the neural basis of human social anxiety: a diagnostic and therapeutic imperativeQ48102710
The early course of schizophrenia and depression*.Q48823951
Psychological autopsy of completed suicide in children and adolescentsQ49201340
Vulnerability factors in Sylvia Plath's suicideQ50253844
Factors predicting suicide in psychotic patients.Q50544207
The 15-year outcome of Chinese patients with schizophrenia in Hong Kong.Q50862532
Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia.Q50936677
Life satisfaction and suicidal attempts among persons with schizophreniaQ51015049
Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study.Q51026926
Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study.Q51068243
Cognitive behavioral therapy reduces suicidal ideation in schizophrenia: results from a randomized controlled trial.Q51902335
Reducing suicidal ideation in depressed older primary care patients.Q51911527
Depression in the long-term course of schizophrenia.Q51928374
Suicide attempts amongst elderly schizophrenia patients: a 10-year case-control study.Q51937343
Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia.Q51956472
Mental disorder in elderly suicides: a case-control study.Q51959370
Mental disorders and cause-specific mortality.Q51961731
Cognitive approach to depression and suicidal thinking in psychosis. 1. Ontogeny of post-psychotic depression.Q51971734
Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up.Q51985870
Mental disorders in elderly suicide.Q52019510
Suicide rates among public mental health patients.Q52097833
Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.Q53360074
Functional impairment in older schizophrenic persons. Toward a conceptual model.Q53516819
Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.Q53589905
Critical treatment issues in suicide among schizophrenics.Q53812243
Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with Schizophrenia in Quebec and Saskatchewan: A retrospective database studyQ57589554
P433issue3
P921main subjectsuicide preventionQ3298118
suicideQ10737
schizophreniaQ41112
suicide riskQ47319077
P304page(s)379-393
P577publication date2011-06-01
P1433published inAging HealthQ15751271
P1476titleSuicidal behavior in the older patient with schizophrenia
P478volume7

Reverse relations

cites work (P2860)
Q46114771Escape from Discrepancy: Self-Esteem and Quality of Life as Predictors of Current Suicidal Ideation Among Individuals with Schizophrenia
Q37715480Suicidal ideation and suicidal behaviour in delusional disorder: a clinical overview.

Search more.